Howard Wang

Howard Wang focuses on patent litigation, opinion and counseling related to pharmaceutical, life sciences, medical device and chemical fields, particularly in Hatch-Waxman matters. Over the past 20 years, Mr. Wang has represented numerous corporate clients, including those based in U.S., India and China, in complex patent litigations, particularly Hatch-Waxman and ANDA litigations, and obtained favorable judgments or settlements. He has handled patent disputes involving a broad range of pharmaceutical subject matters, including drug compound, composition, formulation, process, polymorph, impurity, pharmacokinetics, administration and method of use.  Mr. Wang also frequently provides legal opinions and counseling on legal and patent issues and strategies in connection with product development, regulatory filing, commercialization and business transactions, including patent licensing.

Mr. Wang is admitted to the bars of New Jersey and New York and the U.S. federal courts, including U.S. Court of Appeals for the Federal Circuit.  He is a registered patent attorney before the U.S. Patent and Trademark Office (USPTO). Mr. Wang graduated cum laude and received his J.D. from the University of Illinois College of Law and was a member of the Law Review.

Mr. Wang’s legal practice is strengthened by his substantial scientific background and extensive experience in chemistry and pharmaceutical industry. Prior to his legal career, he obtained a BS degree in Chemistry from the University of Science and Technology of China (USTC) and a MS degree in Organic Chemistry from University of Pittsburgh and studied as a PhD candidate at Yale University. He also worked in process research and development in a major international pharmaceutical company and was a co-inventor of a U.S. patent and co-author of a number of scientific publications. Mr. Wang has been an invited speaker on U.S. patent law and Hatch-Waxman litigation in conferences in the U.S. and China.  He is fluent in Mandarin and Cantonese Chinese.